Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

James Hay receives funding from the Wellcome Trust (grant 225001/Z/22/Z). The NHS is facing severe pressure this winter as flu cases surge earlier than usual, with some calling it “super flu”. Here’s ...